Lomitapide Mesylate
| CAS No. | 202914-84-9 | Cat. No. | BCP10696 |
| Name | Lomitapide Mesylate | ||
| Synonyms | AEGR 733 mesylate; AEGR733 mesylate; AEGR-733 mesylate; BMS 201038 mesylate; BMS-201038 mesylate; BMS201038 mesylate; BMS 201038-04; | ||
| Formula | C39H37F6N3O2·CH4O3S | M. Wt | 789.83 |
| Description | Lomitapide is a MTP inhibitor. Lomitapid is a novel agent for the treatment of homozygous familial hypercholesterolemia. Lomitapide is an orally active inhibitor of microsomal triglyceride transfer protein that is indicated as an adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available for the reduction of LDL-C, total cholesterol, apolipoprotein B, and non-high-density lipoprotein cholesterol in adult patients with HoFH. | ||
| Pathways | Others Pathway | ||
| Targets | Others | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.